XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Data - Revenues by Geographic Areas (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]        
Revenues $ 4,907 $ 4,253 $ 10,223 $ 8,479
Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 2,311 2,151 4,572 4,241
Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 1,586 1,113 3,565 2,236
Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 1,011 990 2,086 2,002
United States        
Segment Reporting Information [Line Items]        
Revenues 2,462 2,415 5,592 4,845
United States | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 1,220 1,200 2,494 2,404
United States | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 576 522 1,710 1,060
United States | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 666 693 1,388 1,381
International        
Segment Reporting Information [Line Items]        
Revenues 2,446 1,839 4,631 3,634
International | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 1,091 951 2,078 1,836
International | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 1,010 591 1,855 1,176
International | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 345 297 698 621
Medication Delivery Solutions | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 999 904 2,006 1,852
Medication Delivery Solutions | United States | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 531 518 1,099 1,038
Medication Delivery Solutions | International | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 468 386 908 814
Medication Management Solutions | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 566 568 1,196 1,143
Medication Management Solutions | United States | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 440 449 917 912
Medication Management Solutions | International | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 126 119 278 231
Diabetes Care | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 284 278 569 547
Diabetes Care | United States | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 148 142 298 281
Diabetes Care | International | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 135 137 271 266
Pharmaceutical Systems | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 462 400 801 699
Pharmaceutical Systems | United States | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 100 91 180 174
Pharmaceutical Systems | International | Operating Segments | Medical        
Segment Reporting Information [Line Items]        
Revenues 361 309 621 525
Integrated Diagnostic Solutions | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 1,261 833 2,928 1,633
Integrated Diagnostic Solutions | United States | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 454 413 1,469 799
Integrated Diagnostic Solutions | International | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 807 420 1,459 834
Biosciences | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 325 280 637 603
Biosciences | United States | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 121 108 241 260
Biosciences | International | Operating Segments | Life Sciences        
Segment Reporting Information [Line Items]        
Revenues 204 172 396 342
Surgery | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 292 312 624 638
Surgery | United States | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 227 249 489 505
Surgery | International | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 65 63 135 133
Peripheral Intervention | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 420 399 846 794
Peripheral Intervention | United States | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 222 242 454 467
Peripheral Intervention | International | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 198 157 392 327
Urology and Critical Care | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 298 279 616 570
Urology and Critical Care | United States | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues 217 202 445 409
Urology and Critical Care | International | Operating Segments | Interventional        
Segment Reporting Information [Line Items]        
Revenues $ 82 $ 76 $ 171 $ 161